Drug Profile
Topical ropivacaine
Alternative Names: Ropivacaine DuraPeelLatest Information Update: 31 Dec 2021
Price :
$50
*
At a glance
- Originator ZARS Pharma
- Developer Nuvo Pharmaceuticals
- Class Anilides; Local anaesthetics; Non-opioid analgesics; Piperidines; Small molecules
- Mechanism of Action Potassium channel antagonists; Sodium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Neuropathic pain
Most Recent Events
- 18 Dec 2020 Nuvo Pharmaceuticals is now called Miravo Healthcare
- 04 Oct 2019 Discontinued - Phase-II for Neuropathic pain in Canada (Topical)